2026 Hirokazu Oguni: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	46	6717	6179	2914	2620	199	7663

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

6717

6179

2914

2620

199

7663

Overview

Hirokazu Oguni is affiliated with the University of California, Los Angeles in the United States. Their research spans multiple areas primarily within medicine, biochemistry, genetics, and molecular biology, with significant contributions to neuroscience. The scientist's work covers various subfields, including psychiatry and mental health, molecular biology, genetics, cellular and molecular neuroscience, and cognitive neuroscience.

Oguni's main topics of research focus on epilepsy research and treatment, neuroscience and neuropharmacology research, EEG and brain-computer interfaces, metabolism and genetic disorders, pharmacological effects and toxicity studies, diet and metabolism studies, as well as digestive system and related health issues.

The publication record includes articles in several scientific venues, with frequent publications appearing in:

Brain and Development
European Journal of Paediatric Neurology
Epileptic Disorders
PubMed
Epilepsia Open

Selected recent papers include:

"Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group" (2020), published in Epilepsia Open
"Epilepsy with myoclonic-atonic seizures, also known as Doose syndrome: Modification of the diagnostic criteria" (2021), published in European Journal of Paediatric Neurology
"CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate" (2022), published in Scientific Reports
"Non-lesional late-onset epilepsy in the elderly Japanese patients: Presenting characteristics and seizure outcomes with regard to comorbid dementia" (2022), published in Journal of Clinical Neuroscience
"Low-dose phenobarbital for epilepsy with myoclonic absences: A case report" (2021), published in Brain and Development

Oguni frequently collaborates with other researchers. Notable coauthors include Susumu Ito, Satoru Nagata, Aiko Nishikawa, Yui Otani, and Toshimitsu Suzuki.

Best Publications

Severe myoclonic epilepsy in infancy: Dravet syndrome.

Charlotte Dravet;Michelle Bureau;Hirokazu Oguni;Yukio Fukuyama

667
Citations
Mutations in EFHC1 cause juvenile myoclonic epilepsy

Toshimitsu Suzuki;Toshimitsu Suzuki;Antonio V Delgado-Escueta;Kripamoy Aguan;Maria E Alonso

429
Citations
Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood

H. Oguni;T. Tanaka;K. Hayashi;M. Funatsuka

251
Citations
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group.

Joerg Klepper;Cigdem Akman;Marisa Armeno;Stéphane Auvin

245
Citations
Mutations of Neuronal Voltage-gated Na+ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB)

Goryu Fukuma;Hirokazu Oguni;Yukiyoshi Shirasaka;Kazuyoshi Watanabe

241
Citations
Dravet syndrome (severe myoclonic epilepsy in infancy)

Charlotte Dravet;Hirokazu Oguni

214
Citations
Panayiotopoulos syndrome: a consensus view

Colin Ferrie;Roberto Caraballo;Athanasios Covanis;Veysi Demirbilek

212
Citations
Severe myoclonic epilepsy in infants – a review based on the Tokyo Women's Medical University series of 84 cases

Hirokazu Oguni;Kitami Hayashi;Yutaka Awaya;Yukio Fukuyama

210
Citations
Anterior callosotomy in the treatment of medically intractable epilepsies: a study of 43 patients with a mean follow-up of 39 months.

Hirokazu Oguni;André Olivier;Frederick Andermann;Joseph Comair

195
Citations
A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome

Yasushi Ito;Hirokazu Oguni;Susumu Ito;Miyako Oguni

176
Citations
Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.

K. Kanai;S. Hirose;H. Oguni;G. Fukuma

162
Citations
Stiripentol open study in Japanese patients with Dravet syndrome.

Yushi Inoue;Yoko Ohtsuka;Hirokazu Oguni;Jun Tohyama

149
Citations
Long-Term Prognosis of Lennox-Gastaut Syndrome

Hirokazu Oguni;Kitami Hayashi;Makiko Osawa

149
Citations
Autonomic status epilepticus in panayiotopoulos syndrome and other childhood and adult epilepsies: A consensus view

Colin D. Ferrie;Roberto Caraballo;Athanasios Covanis;Veysi Demirbilek

148
Citations
STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study.

Motoko Otsuka;Hirokazu Oguni;Jao-Shwann Liang;Hiroko Ikeda

147
Citations
The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 1)†

Michalis Koutroumanidis;Alexis Arzimanoglou;Roberto Caraballo;Sushma Goyal

128
Citations
Study on the early-onset variant of benign childhood epilepsy with occipital paroxysms otherwise described as early-onset benign occipital seizure susceptibility syndrome.

Hirokazu Oguni;Kitami Hayashi;Kaoru Imai;Yukiko Hirano

128
Citations
Genotype–phenotype correlations in alternating hemiplegia of childhood

Masayuki Sasaki;Atsushi Ishii;Yoshiaki Saito;Naoya Morisada

124
Citations
A comparative study of high-dose and low-dose ACTH therapy for West syndrome

Shigeru Yanagaki;Hirokazu Oguni;Kitami Hayashi;Kaoru Imai

119
Citations
Mutational analysis of CACNA1G in idiopathic generalized epilepsy

Baljinder Singh;Arnaud Monteil;Isabelle Bidaud;Yoshihisa Sugimoto

111
Citations